Guidance for industry: Immunogenicity Assessment for therapeutic protein products
Since 1 June 2025 that authorisation should follow a face-to-face assessment
Perucca E, Bialer M, White HS (2023) New GABA-targeting therapies for the treatment of seizures and epilepsy: I
Related Products Best-Selling Peptides / All Peptides Retatrutide Triple receptor agonist peptide (GLP-1/GIP/GCGR), 5mg lyophilized Best-Selling Peptides / All Peptides Tirzepatide Dual GIP/GLP-1 receptor agonist, 5mg lyophilized Best-Selling Peptides / All Peptides BPC-157 5MG Body Protection Compound-157, 5mg lyophilized peptide Best-Selling Peptides / All Peptides TB-500 Thymosin Beta-4 Fragment, 5mg lyophilized peptide
GHK-Cu has generated interest among researchers investigating various biological systems, including those studying sex-specific responses to peptide compounds
Description GHK-Cu is a synthetic copper-binding tripeptide (Copper Tripeptide-1) supplied as a lyophilized research material for in vitro and analytical laboratory applications